Background

Mr. Daniel K. Turner, also known as Dan, III, CPA, serves as a Managing Director, General Partner, and Managing Member since 1993 at Montreux Equity Partners. Mr. Turner founded Montreux. He served as Executive officer at PricewaterhouseCoopers LLP in the high technology group. He served as Head, Turnaround and Restructuring Group at Berkeley International Capital Corporation. Previously, he held leadership positions as Principal in the Turnaround Group for Berkeley ... International and founding Chief Financial Officer of Oclassen Pharmaceuticals. He serves as a Director of moksha8 Pharmaceuticals, Inc.; Global Consolidated Aesthetics Ltd.; Pure Life Renal; Sequel Pharmaceuticals, Inc. Mr. Turner is a Member of the Advisory Board of the Lester Center at the Haas School of Business at the University of California, Berkeley. He serves as a Director at Paymap Inc., since May 1993. He served as a Director of Tobira Therapeutics, Inc. until April 2014. He served as a Director of EPIRUS Biopharmaceuticals, Inc. He served as a Director of NeurogesX, Inc., until October 2007, Orexigen Therapeutics, Inc. from April 2005 to April 2012, Transcept Pharmaceuticals, Inc. from July 2003 to June 2011 and Somaxon Pharmaceuticals, Inc. from April 2004 to August 2008. He served as a Director of NovaCardia, Inc., Glaukos Corporation, Peninsula Pharmaceticals, Renal CarePartners, Inc., and SkinMedica, Inc. Mr. Turner has 25 years of experience as an entrepreneur, operating manager and venture capitalist. He has invested in companies across consumer, healthcare services, pharmaceuticals and technology companies. Mr. Turner is a Certified Public Accountant. He holds a B.S. in Accounting and Business Administration from California State University, Sacramento and attended the M.B.A. program at the Haas School of Business at the University of California, Berkeley, where he has established the Turner Fellowship.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.